These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7823751)

  • 1. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Nightingale SD
    Lancet; 1995 Jan; 345(8944):265. PubMed ID: 7823751
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    von Reyn CF; Brown ST; Arbeit RD
    N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 8129826
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylaxis of Mycobacterium avium complex infections in AIDS.
    Klaus BD
    Nurse Pract; 1995 Jun; 20(6):80-1. PubMed ID: 7659325
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Reichman LB; McDonald RJ; Mangura BT
    N Engl J Med; 1994 Feb; 330(6):437-8. PubMed ID: 8129827
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifabutin prophylaxis against Mycobacterium avium complex disease.
    Goldschmidt RH; Dong BJ
    J Am Board Fam Pract; 1994; 7(1):80-3. PubMed ID: 7907837
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex.
    Böttger EC; Wallace RJ
    Lancet; 1994 Nov; 344(8935):1506-7. PubMed ID: 7734014
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.
    Stephenson JM; Williams IG
    Genitourin Med; 1996 Aug; 72(4):272-6. PubMed ID: 8976833
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifabutin-associated uveitis during prophylaxis for Mycobacterium avium complex infection.
    Rifai A; Peyman GA; Daun M; Wafapoor H
    Arch Ophthalmol; 1995 Jun; 113(6):707. PubMed ID: 7786206
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Goldschmidt RH; Hearst N; Chambers DB
    N Engl J Med; 1994 Feb; 330(6):436-7; author reply 438. PubMed ID: 7904328
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Zbrozek AS
    N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 7904329
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifabutin prophylaxis and uveitis.
    Fuller JD; Stanfield LE; Craven DE
    N Engl J Med; 1994 May; 330(18):1315-6. PubMed ID: 8145794
    [No Abstract]   [Full Text] [Related]  

  • 13. Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.
    Pozniak A; Nelson MR
    Genitourin Med; 1996 Aug; 72(4):269-71. PubMed ID: 8976832
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole and enhanced effect of rifabutin prophylaxis.
    Narang PK; Trapnell CB; Schoenfelder JR; Lavelle JP; Bianchine JR
    N Engl J Med; 1994 May; 330(18):1316-7. PubMed ID: 7695673
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection.
    Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W
    Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia.
    Arevalo JF; Freeman WR
    Am J Ophthalmol; 2000 Mar; 129(3):410-1. PubMed ID: 10755956
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment review. Rifabutin.
    Co M
    J Assoc Nurses AIDS Care; 1994; 5(1):45-50. PubMed ID: 8167311
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis.
    Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T
    AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.